Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 May 2021 | Story Xolisa Mnukwa
The 2021 Kovsie ACT Eco-vehicle race puts students’ sustainable energy and critical thinking skills to the test.

The University of the Free State (UFS) Division of Student Affairs’ (DSA) Director of Student Life, Dr WP Wahl, believes the knowledge and skills that students have gained through participating in the 2021 Eco-vehicle project will position them more optimally in the future world of work. “We are also tremendously grateful for the project funding received from merSETA; without their support, none of this would have been possible,” he remarked.

The Kovsie ACT Eco-vehicle race, in conjunction with the overall programme, was established to encourage students to learn more about the technology and logic behind sustainable energy sources and how this can influence the future global society.

This year’s events witnessed students competing according to their UFS residence teams, with Sonnedou, Legatum, Kestell (SonLeTell); Soetdoring, Beyers Naude, Arista (Soetbeyrista); and Roosmaryn, Kagiso, Karee (Kar-is-myn) ending in first, second, and third place respectively, obtaining the highest scores for the races they competed in.

Anton Calitz, Electrical Engineer in University Estates who was the announcer on the day, described the event as one that exceeded his wildest expectations. “From a sustainable energy point of view, the eco-vehicle race results really turned the tables, with lower energy usage per lap being successfully recorded – as anticipated,” he further added.

Andre van Wyk, Client Liaison Officer of merSETA (Manufacturing, Engineering and Related Services Seta) for the Free State and Northern Cape – as one of the sponsors of the innovative programme – extended warm congratulations to the UFS for hosting an outstanding event. He further applauded the university for its resourcefulness in virtually adding electronic media broadcasts to extend the event to the entire UFS community.

“The Kovsie ACT Eco-vehicle programme was eye-opening and exposed me to the broad field of electronics. It definitely came as a challenge – one I had not anticipated on that level, because at times I couldn’t even see what all the building was leading to, but I just had to put my mind and hands to work – it pushed me to think critically and creatively. I was honoured to have been part of this entire experience and I’m grateful to Anton and his team, as well as the Kovsie ACT office, for being a constant support structure throughout the process, as it was not easy.” 

These were the humble words of Sinegugu Sibisi, a University of the Free State (UFS) student who was part of the 2021 Kovsie ACT Eco-vehicle race, where sustainable energy was at the order of the day.

For more information about the Kovsie ACT eco-vehicle skills programme, email ACT at ACT@ufs.ac.za
 

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept